 GERMANTOWN, Md.--BUSINESS WIRE--Senseonics Holdings, Inc. NYSE American: SENS, a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring CGM systems for people with diabetes, today announced plans to participate in the upcoming virtual H.C. Wainwright Global Investment Conference. Management is scheduled to participate and hold one on-one-meetings Wednesday, September 15, 2021. A presentation webcast will be avail 